Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
ST. LOUIS, May 04, 2018 -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 first quarter ended March 31, 2018 on Monday, May 14, 2018 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.
| What: | Stereotaxis first quarter 2018 financial results conference call | |||||||
| When: | Monday, May 14th at 10:00 a.m. Eastern Time (7:00 a.m. PT) | |||||||
| Dial In Number: | To access the live call, dial 800-289-0438 (US and Canada) or 323-794-2423 (International) and give the participant pass code 7909480. | |||||||
| Webcast: | To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at www.stereotaxis.com. | |||||||
| Call Replay: | A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through Monday, May 21, 2018. To access the replay dial-in information, please click here. | |||||||
About Stereotaxis
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.
Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Martin C. Stammer
Chief Financial Officer
314-678-6100
[email protected]
